World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
63367
World Ranking
3437
National Ranking
1892

Neal S. Kleiman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Neal S. Kleiman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 717 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Neal S. Kleiman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Neal S. Kleiman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Neal S. Kleiman is affiliated with Houston Methodist in the United States and has contributed extensively to the field of medicine, with a strong focus on cardiology and cardiovascular medicine. Their research spans a variety of specialized subfields including epidemiology, surgery, pulmonary and respiratory medicine, and radiology, nuclear medicine, and imaging.

The scientist's work primarily concentrates on topics such as cardiac valve diseases and treatments, infective endocarditis diagnosis and management, cardiac imaging and diagnostics, coronary interventions and diagnostics, cardiovascular function and risk factors, aortic disease and treatment approaches, and cardiac structural anomalies and repair.

Neal S. Kleiman has published numerous papers in leading cardiovascular journals. Recent notable publications include:

  • Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation, 2020, JAMA
  • Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study, 2020, Journal of the American College of Cardiology
  • 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis, 2023, Journal of the American College of Cardiology
  • Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients, 2022, JAMA Cardiology
  • Surgical Explantation After TAVR Failure, 2021, JACC: Cardiovascular Interventions

The scientist frequently collaborates with other authors in the field, including Sachin S. Goel, Michael J. Reardon, Syed Zaid, Stephen H. Little, and Nadeen Faza. These collaborations reflect a broad network within cardiovascular research and interventions.

Neal S. Kleiman's publications are often found in prominent cardiovascular and cardiology journals, including:

  • Journal of the American College of Cardiology
  • JACC: Cardiovascular Interventions
  • Cardiovascular Revascularization Medicine
  • The American Journal of Cardiology
  • Journal of the Society for Cardiovascular Angiography & Interventions

Best Publications

  • Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients

    Jeffrey J Popma;G Michael Deeb;Steven J Yakubov;Mubashir Mumtaz

  • Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis

    David H. Adams;Jeffrey J. Popma;Michael J. Reardon;Steven J. Yakubov

  • Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

    M. J. Reardon;N. M. Van Mieghem;J. J. Popma;N. S. Kleiman

  • Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

    Ohman Em;Armstrong Pw;Christenson Rh;Granger Cb

  • Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial

    A. Michael Lincoff;John A. Bittl;Robert A. Harrington;Frederick Feit

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

    Jeffrey J. Popma;David H. Adams;Michael J. Reardon;Steven J. Yakubov

  • Abciximab Facilitates the Rate and Extent of Thrombolysis Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 Trial

    Elliott M. Antman;Robert P. Giugliano;C. Michael Gibson;Carolyn H. McCabe

  • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

    EJ Topol;AM Lincoff;RM Califf;EM Ohman

  • Risk Factors, Angiographic Patterns, and Outcomes in Patients With Ventricular Septal Defect Complicating Acute Myocardial Infarction

    Brian S. Crenshaw;Christopher B. Granger;Yochai Birnbaum;Karen S. Pieper

  • A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

    William W. O'Neill;Neal S. Kleiman;Jeffrey Moses;Jose P.S. Henriques

  • Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2 Double-Blind, Randomized, Controlled Clinical Trial

    Michael Simons;Brian H. Annex;Roger J. Laham;Neal Kleiman

  • Intravenous Platelet Blockade with Cangrelor during PCI

    Deepak L. Bhatt;A. Michael Lincoff;C. Michael Gibson;Gregg W. Stone

  • Dobutamine Echocardiography in Myocardial Hibernation Optimal Dose and Accuracy in Predicting Recovery of Ventricular Function After Coronary Angioplasty

    Imran Afridi;Neal S. Kleiman;Albert E. Raizner;William A. Zoghbi

  • Myonecrosis After Revascularization Procedures

    Robert M. Califf;Alaa E. Abdelmeguid;Richard E. Kuntz;Jeffrey J. Popma

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention: The Role of Dual Drug Resistance

    Eli I. Lev;Rajnikant T. Patel;Kelly J. Maresh;Sasidhar Guthikonda

  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

    Deepak L. Bhatt;Matthew T. Roe;Eric D. Peterson;Yun Li

  • Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

    Marco Roffi;Derek P. Chew;Debabrata Mukherjee;Deepak L. Bhatt

  • Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.

    A. Michael Lincoff;Neal S. Kleiman;Dean J. Kereiakes;Frederick Feit

Frequent Co-Authors

Eric J. Topol
Eric J. Topol Scripps Research Institute
Robert M. Califf
Robert M. Califf Duke University
Michael J. Reardon
Michael J. Reardon Houston Methodist
Jeffrey J. Popma
Jeffrey J. Popma Beth Israel Deaconess Medical Center
Robert A. Harrington
Robert A. Harrington Cornell University
A. Michael Lincoff
A. Michael Lincoff Cleveland Clinic
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Harvey D. White
Harvey D. White Auckland City Hospital
Dean J. Kereiakes
Dean J. Kereiakes The Christ Hospital Health Network
Michael J. Pencina
Michael J. Pencina Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in healthcare doesn’t always mean traditional medical school. There are a variety of online degrees and alternative pathways worth exploring, especially for those who want a flexible and accessible route into the medical field.

For example, some students prefer direct entry nursing programs, which allow individuals with non-nursing backgrounds to transition efficiently into a nursing career. Others may look for a medical billing and coding schools online to train for in-demand roles in the administrative side of healthcare.

If entrance exams are a concern, you may find a nursing school that don't require teas or HESI exams, making it easier to start your studies. Additionally, pursuing a career in management is possible with an online healthcare management degree, which prepares graduates for leadership roles across healthcare organizations.

Exploring these related online degrees and career options ensures you can find a path that works with your career goals, schedule, and educational background.

Best Scientists Citing Neal S. Kleiman

Trending Scientists

Recently Published Articles